No Data
No Data
No Data
No Data
No Data
ResMed Fiscal Q3 Non-GAAP Earnings, Revenue Increase; Shares Rise After Hours
ResMed reported fiscal Q3 non-GAAP earnings late Thursday of $2.13 per diluted share, up from $1.68 a year earlier.
MT NewswiresApr 25 19:59 ET
ResMed Is Maintained at Sector Perform by RBC Capital
ResMed Is Maintained at Sector Perform by RBC Capital
Dow Jones12:03 ET
ResMed Stock Soars 15% After Strong Earnings
By Emily Dattilo Shares of ResMed were trading sharply higher after the medical devices company filed a quarterly report that left Wall Street cheering. In premarket trading Friday, ResMed stock was
Barron'sApr 26 10:29 ET
ResMed Up Over 14%, on Pace for Largest Percent Increase Since March 2020 -- Data Talk
ResMed Inc. (RMD) is currently at $209.44, up $26.02 or 14.19% --Would be highest close since Aug. 3, 2023, when it closed at $219.95 --On pace for largest percent increase since March 17, 2020, whe
Dow JonesApr 26 10:07 ET
Research Alert: CFRA Maintains Hold Opinion On Shares Of Resmed Inc.
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We increase our 12-month target price by
MT NewswiresApr 26 09:45 ET
S&P 500 Futures Climb In Premarket Trading; Snap, Alphabet Lead
This article was automatically generated by Barrons.com using technology from Automated Insights. With U.S. stock markets set to open in two hours, Snap Inc. (SNAP) was up 26.0% in pre-market trading
Dow JonesApr 26 07:31 ET
No Data
No Data